These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 25462232)
1. Studies on indolizines. Evaluation of their biological properties as microtubule-interacting agents and as melanoma targeting compounds. Ghinet A; Abuhaie CM; Gautret P; Rigo B; Dubois J; Farce A; Belei D; Bîcu E Eur J Med Chem; 2015 Jan; 89():115-27. PubMed ID: 25462232 [TBL] [Abstract][Full Text] [Related]
2. Discovery of indolizines containing triazine moiety as new leads for the development of antitumoral agents targeting mitotic events. Lucescu L; Ghinet A; Belei D; Rigo B; Dubois J; Bîcu E Bioorg Med Chem Lett; 2015 Sep; 25(18):3975-9. PubMed ID: 26227778 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of fluoro analogues of antimitotic phenstatin. Ghinet A; Tourteau A; Rigo B; Stocker V; Leman M; Farce A; Dubois J; Gautret P Bioorg Med Chem; 2013 Jun; 21(11):2932-40. PubMed ID: 23618708 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic substituted indolizines as new colchicine site tubulin polymerisation inhibitors. Sardaru MC; Craciun AM; Al Matarneh CM; Sandu IA; Amarandi RM; Popovici L; Ciobanu CI; Peptanariu D; Pinteala M; Mangalagiu II; Danac R J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1581-1595. PubMed ID: 32752898 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents. Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783 [TBL] [Abstract][Full Text] [Related]
6. Indolizine-phenothiazine hybrids as the first dual inhibitors of tubulin polymerization and farnesyltransferase with synergistic antitumor activity. Moise IM; Bîcu E; Farce A; Dubois J; Ghinet A Bioorg Chem; 2020 Oct; 103():104184. PubMed ID: 32891861 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and biological evaluation of anti-cancer indolizine derivatives via inhibiting β-catenin activity and activating p53. Moon SH; Jung Y; Kim SH; Kim I Bioorg Med Chem Lett; 2016 Jan; 26(1):110-3. PubMed ID: 26608553 [TBL] [Abstract][Full Text] [Related]
8. [3 + 2]-Annulation of pyridinium ylides with 1-chloro-2-nitrostyrenes unveils a tubulin polymerization inhibitor. Aksenov AV; Arutiunov NA; Kirilov NK; Aksenov DA; Grishin IY; Aksenov NA; Wang H; Du L; Betancourt T; Pelly SC; Kornienko A; Rubin M Org Biomol Chem; 2021 Sep; 19(33):7234-7245. PubMed ID: 34387294 [TBL] [Abstract][Full Text] [Related]
9. Biological evaluation of indolizine-chalcone hybrids as new anticancer agents. Park S; Kim EH; Kim J; Kim SH; Kim I Eur J Med Chem; 2018 Jan; 144():435-443. PubMed ID: 29288944 [TBL] [Abstract][Full Text] [Related]
10. New indolizines with phenanthroline skeleton: Synthesis, structure, antimycobacterial and anticancer evaluation. Danac R; Al Matarneh CM; Shova S; Daniloaia T; Balan M; Mangalagiu II Bioorg Med Chem; 2015 May; 23(10):2318-27. PubMed ID: 25882524 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro cytotoxicity evaluation of novel naphthindolizinedione derivatives. Defant A; Guella G; Mancini I Arch Pharm (Weinheim); 2007 Mar; 340(3):147-53. PubMed ID: 17315260 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticancer activity of analogues of phenstatin, with a phenothiazine A-ring, as a new class of microtubule-targeting agents. Abuhaie CM; Bîcu E; Rigo B; Gautret P; Belei D; Farce A; Dubois J; Ghinet A Bioorg Med Chem Lett; 2013 Jan; 23(1):147-52. PubMed ID: 23200248 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiproliferative activity of indolizine derivatives incorporating a cyclopropylcarbonyl group against Hep-G2 cancer cell line. Shen YM; Lv PC; Chen W; Liu PG; Zhang MZ; Zhu HL Eur J Med Chem; 2010 Jul; 45(7):3184-90. PubMed ID: 20304535 [TBL] [Abstract][Full Text] [Related]
14. 3-Amino-thieno[2,3-b]pyridines as microtubule-destabilising agents: Molecular modelling and biological evaluation in the sea urchin embryo and human cancer cells. Eurtivong C; Semenov V; Semenova M; Konyushkin L; Atamanenko O; Reynisson J; Kiselyov A Bioorg Med Chem; 2017 Jan; 25(2):658-664. PubMed ID: 27956038 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of phenanthroindolizidine alkaloids and evaluation of their antitumor activities and toxicities. Ikeda T; Yaegashi T; Matsuzaki T; Yamazaki R; Hashimoto S; Sawada S Bioorg Med Chem Lett; 2011 Oct; 21(19):5978-81. PubMed ID: 21865039 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of heteroaromatic 6,7-diaryl-2,3,8,8a-tetrahydroindolizin-5(1H)-ones for cytotoxicity against the HCT-116 colon cancer cell line. Kimball FS; Himes RH; Georg GI Bioorg Med Chem Lett; 2008 Jun; 18(11):3248-50. PubMed ID: 18479919 [TBL] [Abstract][Full Text] [Related]
17. Anticancer activity of novel pyrido[2,3-b]indolizine derivatives: the relevance of phenolic substituents. Boot A; Brito A; VAN Wezel T; Morreau H; Costa M; Proença F Anticancer Res; 2014 Apr; 34(4):1673-7. PubMed ID: 24692696 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of B-ring analogues of (-)-rhazinilam. Décor A; Monse B; Martin MT; Chiaroni A; Thoret S; Guénard D; Guéritte F; Baudoin O Bioorg Med Chem; 2006 Apr; 14(7):2314-32. PubMed ID: 16314101 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs. Baechler SA; Fehr M; Habermeyer M; Hofmann A; Merz KH; Fiebig HH; Marko D; Eisenbrand G Bioorg Med Chem; 2013 Feb; 21(3):814-23. PubMed ID: 23266176 [TBL] [Abstract][Full Text] [Related]
20. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies. Park JH; El-Gamal MI; Lee YS; Oh CH Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]